Translational control as a driver of tumor plasticity, metastasis, and therapeutic resistance in triple-negative breast cancer
Disease and Therapeutics · 2026 · 3 · 100018
DOI: 10.1016/j.dist.2026.100018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease and Therapeutics, 2026. Verfasst von Tiffany J. Rios-Fuller und 2 weiteren Autor:innen. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: American Cancer Society Inc, National Institutes of Health National Cancer Institute, National Institute on Minority Health and Health Disparities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- American Cancer Society Inc
- National Institutes of Health National Cancer Institute
- National Institute on Minority Health and Health Disparities
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
- The Breast Cancer Research Foundation Inc
Zitieren
APA
Rios-Fuller, T. J., Saavedra, H. I., & Schneider, R. J. (2026). Translational control as a driver of tumor plasticity, metastasis, and therapeutic resistance in triple-negative breast cancer. Disease and Therapeutics, 3, 100018. https://doi.org/10.1016/j.dist.2026.100018
Vancouver
Rios-Fuller TJ, Saavedra HI, Schneider RJ. Translational control as a driver of tumor plasticity, metastasis, and therapeutic resistance in triple-negative breast cancer. Disease and Therapeutics. 2026;3:100018. doi:10.1016/j.dist.2026.100018
BibTeX
@article{RiosFuller2026,
author = {Rios-Fuller, Tiffany J. and Saavedra, Harold I. and Schneider, Robert J.},
title = {Translational control as a driver of tumor plasticity, metastasis, and therapeutic resistance in triple-negative breast cancer},
journal = {Disease and Therapeutics},
year = {2026},
volume = {3},
pages = {100018},
doi = {10.1016/j.dist.2026.100018}
}
EUVIMED